| 0 |
LACK OF APPLICATION SITE ROTATION |
21 |
0.1391 |
| 1 |
APPLICATION SITE STREAKING |
1 |
0.0769 |
| 2 |
PREGNANCY WITH CONTRACEPTIVE PATCH |
12 |
0.0682 |
| 3 |
GASTROPARESIS POSTOPERATIVE |
1 |
0.0588 |
| 4 |
POSTPARTUM ANXIETY |
1 |
0.0500 |
| 5 |
SEXUALLY ACTIVE |
1 |
0.0455 |
| 6 |
MICROSCOPIC ENTERITIS |
1 |
0.0435 |
| 7 |
RETIREMENT |
1 |
0.0400 |
| 8 |
ADMINISTRATION SITE SCAB |
1 |
0.0385 |
| 9 |
FEAR OF PREGNANCY |
1 |
0.0303 |
| 10 |
APPLICATION SITE MASS |
8 |
0.0292 |
| 11 |
SPONTANEOUS RUPTURE OF MEMBRANES |
1 |
0.0286 |
| 12 |
HEREDITARY ATAXIA |
1 |
0.0286 |
| 13 |
APPLICATION SITE PHOTOSENSITIVITY REACTION |
1 |
0.0270 |
| 14 |
APPLICATION SITE ECZEMA |
2 |
0.0230 |
| 15 |
PRODUCT ADHESION ISSUE |
708 |
0.0198 |
| 16 |
HUMAN CHORIONIC GONADOTROPIN ABNORMAL |
1 |
0.0172 |
| 17 |
OCCUPATIONAL PROBLEM ENVIRONMENTAL |
1 |
0.0169 |
| 18 |
APPLICATION SITE ODOUR |
2 |
0.0138 |
| 19 |
APPLICATION SITE EXTRAVASATION |
1 |
0.0133 |
| 20 |
APPLICATION SITE SCAR |
15 |
0.0120 |
| 21 |
SOMATIC DYSFUNCTION |
1 |
0.0111 |
| 22 |
HYDROSALPINX |
1 |
0.0109 |
| 23 |
OPTIC NERVE NEOPLASM |
1 |
0.0106 |
| 24 |
BIOCHEMICAL PREGNANCY |
1 |
0.0093 |
| 25 |
APPLICATION SITE BRUISE |
9 |
0.0092 |
| 26 |
MESENTERIC ARTERY EMBOLISM |
1 |
0.0092 |
| 27 |
PROGESTERONE INCREASED |
1 |
0.0090 |
| 28 |
APPLICATION SITE RASH |
119 |
0.0086 |
| 29 |
APPLICATION SITE IRRITATION |
105 |
0.0084 |
| 30 |
MENSTRUAL DISCOMFORT |
1 |
0.0083 |
| 31 |
PERINEAL DISORDER |
1 |
0.0083 |
| 32 |
APPLICATION SITE BURN |
40 |
0.0081 |
| 33 |
TRANSIENT APHASIA |
1 |
0.0076 |
| 34 |
PREMENSTRUAL PAIN |
1 |
0.0076 |
| 35 |
APPLICATION SITE PRURITUS |
167 |
0.0074 |
| 36 |
INFLAMMATORY CARCINOMA OF THE BREAST |
1 |
0.0069 |
| 37 |
PORTAL VEIN OCCLUSION |
1 |
0.0068 |
| 38 |
APPLICATION SITE URTICARIA |
15 |
0.0067 |
| 39 |
APPLICATION SITE HYPERSENSITIVITY |
8 |
0.0066 |
| 40 |
METRORRHAGIA |
111 |
0.0065 |
| 41 |
APPLICATION SITE SWELLING |
31 |
0.0062 |
| 42 |
BLADDER CYST |
1 |
0.0062 |
| 43 |
APPLICATION SITE WOUND |
1 |
0.0061 |
| 44 |
APPLICATION SITE INDURATION |
1 |
0.0059 |
| 45 |
BLOOD OESTROGEN ABNORMAL |
1 |
0.0058 |
| 46 |
APPLICATION SITE PERSPIRATION |
1 |
0.0058 |
| 47 |
POLYMENORRHOEA |
20 |
0.0058 |
| 48 |
WITHDRAWAL BLEED |
4 |
0.0055 |
| 49 |
APPLICATION SITE EROSION |
7 |
0.0054 |
| 50 |
APPLICATION SITE DISCOLOURATION |
22 |
0.0054 |
| 51 |
VISUAL SNOW SYNDROME |
1 |
0.0054 |
| 52 |
APPLICATION SITE INJURY |
1 |
0.0053 |
| 53 |
BENIGN HEPATIC NEOPLASM |
1 |
0.0050 |
| 54 |
HIGH RISK PREGNANCY |
2 |
0.0049 |
| 55 |
PREMENSTRUAL DYSPHORIC DISORDER |
1 |
0.0049 |
| 56 |
APPLICATION SITE LACERATION |
2 |
0.0048 |
| 57 |
INTERMENSTRUAL BLEEDING |
27 |
0.0048 |
| 58 |
PREGNANCY ON CONTRACEPTIVE |
7 |
0.0048 |
| 59 |
SKIN PRESSURE MARK |
1 |
0.0047 |
| 60 |
PELVIC FLOOR DYSFUNCTION |
1 |
0.0047 |
| 61 |
APPLICATION SITE PAPULES |
5 |
0.0047 |
| 62 |
ROCKY MOUNTAIN SPOTTED FEVER |
1 |
0.0047 |
| 63 |
APPLICATION SITE SCAB |
10 |
0.0046 |
| 64 |
APPLICATION SITE ERYTHEMA |
121 |
0.0046 |
| 65 |
MENSTRUAL DISORDER |
38 |
0.0046 |
| 66 |
APPLICATION SITE INFLAMMATION |
6 |
0.0043 |
| 67 |
APPLICATION SITE HYPOAESTHESIA |
1 |
0.0043 |
| 68 |
APPLICATION SITE EXFOLIATION |
17 |
0.0041 |
| 69 |
APPLICATION SITE ACNE |
2 |
0.0041 |
| 70 |
APPLICATION SITE WARMTH |
5 |
0.0039 |
| 71 |
APPLICATION SITE VESICLES |
24 |
0.0037 |
| 72 |
APPLICATION SITE REACTION |
26 |
0.0037 |
| 73 |
OLIGOMENORRHOEA |
8 |
0.0037 |
| 74 |
DERMAL ABSORPTION IMPAIRED |
1 |
0.0036 |
| 75 |
CHONDROMALACIA |
1 |
0.0035 |
| 76 |
ROTAVIRUS INFECTION |
2 |
0.0035 |
| 77 |
CHEMICAL BURN |
4 |
0.0035 |
| 78 |
ABDOMINAL WALL DISORDER |
1 |
0.0034 |
| 79 |
BLOOD OESTROGEN INCREASED |
2 |
0.0034 |
| 80 |
PHYSICAL PRODUCT LABEL ISSUE |
4 |
0.0034 |
| 81 |
APPLICATION SITE PAIN |
73 |
0.0033 |
| 82 |
LACK OF ADMINISTRATION SITE ROTATION |
1 |
0.0033 |
| 83 |
APPLICATION SITE DRYNESS |
11 |
0.0032 |
| 84 |
APPLICATION SITE DERMATITIS |
3 |
0.0032 |
| 85 |
MENSTRUATION NORMAL |
1 |
0.0030 |
| 86 |
HEMIPLEGIC MIGRAINE |
1 |
0.0029 |
| 87 |
ASTHMA EXERCISE INDUCED |
1 |
0.0029 |
| 88 |
IMPLANT SITE RASH |
1 |
0.0028 |
| 89 |
BITE |
2 |
0.0028 |
| 90 |
APPLICATION SITE PUSTULES |
1 |
0.0027 |
| 91 |
IMPLANT SITE IRRITATION |
1 |
0.0026 |
| 92 |
MESENTERIC ARTERY THROMBOSIS |
1 |
0.0026 |
| 93 |
LIPID METABOLISM DISORDER |
1 |
0.0026 |
| 94 |
APPLICATION SITE DISCHARGE |
3 |
0.0026 |
| 95 |
HAEMORRHAGIC CYST |
1 |
0.0026 |
| 96 |
APPLICATION SITE HAEMORRHAGE |
7 |
0.0026 |
| 97 |
DELUSIONAL PERCEPTION |
1 |
0.0024 |
| 98 |
APPLICATION SITE PARAESTHESIA |
3 |
0.0023 |
| 99 |
FIBROADENOMA OF BREAST |
1 |
0.0022 |
| 100 |
IMPLANT SITE PRURITUS |
2 |
0.0022 |
| 101 |
CATHETER SITE RASH |
1 |
0.0022 |
| 102 |
PELVIC INFECTION |
1 |
0.0022 |
| 103 |
MANUFACTURING ISSUE |
1 |
0.0022 |
| 104 |
SEXUALLY INAPPROPRIATE BEHAVIOUR |
1 |
0.0021 |
| 105 |
WRONG SCHEDULE |
2 |
0.0021 |
| 106 |
MENOMETRORRHAGIA |
4 |
0.0021 |
| 107 |
DERMATITIS INFECTED |
1 |
0.0020 |
| 108 |
HYPERMOBILITY SYNDROME |
1 |
0.0020 |
| 109 |
APPLICATION SITE INFECTION |
1 |
0.0020 |
| 110 |
UTERINE PAIN |
2 |
0.0019 |
| 111 |
CRYPTOSPORIDIOSIS INFECTION |
1 |
0.0019 |
| 112 |
PRODUCT RESIDUE PRESENT |
10 |
0.0019 |
| 113 |
MORNING SICKNESS |
1 |
0.0018 |
| 114 |
SUSPECTED PRODUCT TAMPERING |
1 |
0.0018 |
| 115 |
ENCEPHALOMALACIA |
1 |
0.0018 |
| 116 |
DYSMENORRHOEA |
23 |
0.0017 |
| 117 |
IRREGULAR BREATHING |
1 |
0.0017 |
| 118 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
344 |
0.0017 |
| 119 |
UTERINE SPASM |
3 |
0.0016 |
| 120 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS PERFORMED IN ERROR |
1 |
0.0016 |
| 121 |
VULVAL DISORDER |
1 |
0.0015 |
| 122 |
PREMENSTRUAL SYNDROME |
2 |
0.0015 |
| 123 |
HORMONE LEVEL ABNORMAL |
7 |
0.0014 |
| 124 |
BLOOD OESTROGEN DECREASED |
1 |
0.0014 |
| 125 |
FLUID IMBALANCE |
1 |
0.0014 |
| 126 |
ANTIBODY TEST ABNORMAL |
1 |
0.0014 |
| 127 |
MENORRHAGIA |
27 |
0.0014 |
| 128 |
SUPPRESSED LACTATION |
1 |
0.0013 |
| 129 |
RUBBER SENSITIVITY |
2 |
0.0013 |
| 130 |
MEDICAL DEVICE SITE DISCOMFORT |
1 |
0.0012 |
| 131 |
CHEMICAL INJURY |
1 |
0.0012 |
| 132 |
HEAVY MENSTRUAL BLEEDING |
11 |
0.0012 |
| 133 |
SEIZURE CLUSTER |
1 |
0.0012 |
| 134 |
MENSTRUATION IRREGULAR |
32 |
0.0012 |
| 135 |
INTENTIONAL DEVICE USE ISSUE |
1 |
0.0012 |
| 136 |
SELF-DESTRUCTIVE BEHAVIOUR |
1 |
0.0011 |
| 137 |
APPLICATION SITE DISCOMFORT |
2 |
0.0011 |
| 138 |
SELECTIVE EATING DISORDER |
1 |
0.0011 |
| 139 |
SUSPECTED PRODUCT QUALITY ISSUE |
2 |
0.0011 |
| 140 |
PRODUCT APPEARANCE CONFUSION |
1 |
0.0011 |
| 141 |
PROGESTERONE RECEPTOR ASSAY POSITIVE |
1 |
0.0011 |
| 142 |
DERMATITIS CONTACT |
12 |
0.0011 |
| 143 |
DRUG DISPENSED TO WRONG PATIENT |
1 |
0.0010 |
| 144 |
VAGINAL DISORDER |
1 |
0.0010 |
| 145 |
EMBOLISM VENOUS |
3 |
0.0010 |
| 146 |
IMPLANT SITE SWELLING |
1 |
0.0010 |
| 147 |
BREAST DISCOMFORT |
1 |
0.0010 |
| 148 |
IMPLANT SITE ERYTHEMA |
1 |
0.0010 |
| 149 |
BREAST TENDERNESS |
7 |
0.0009 |
| 150 |
REACTION TO DRUG EXCIPIENTS |
2 |
0.0009 |
| 151 |
HAEMORRHAGIC DISORDER |
1 |
0.0009 |
| 152 |
BENIGN NEOPLASM |
1 |
0.0009 |
| 153 |
OESTROGEN RECEPTOR ASSAY POSITIVE |
1 |
0.0009 |
| 154 |
VAGINAL HAEMORRHAGE |
37 |
0.0009 |
| 155 |
SKIN WEEPING |
3 |
0.0008 |
| 156 |
MENSTRUATION DELAYED |
9 |
0.0008 |
| 157 |
HYPERAESTHESIA TEETH |
1 |
0.0008 |
| 158 |
CHEMICAL BURN OF SKIN |
2 |
0.0008 |
| 159 |
MOOD SWINGS |
25 |
0.0008 |
| 160 |
ADNEXA UTERI PAIN |
1 |
0.0008 |
| 161 |
WISDOM TEETH REMOVAL |
1 |
0.0008 |
| 162 |
PRODUCT LABEL ISSUE |
5 |
0.0007 |
| 163 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
5 |
0.0007 |
| 164 |
PRODUCT QUALITY ISSUE |
99 |
0.0007 |
| 165 |
CATAPLEXY |
1 |
0.0007 |
| 166 |
GLUTEN SENSITIVITY |
1 |
0.0007 |
| 167 |
SMEAR CERVIX ABNORMAL |
1 |
0.0007 |
| 168 |
SLEEP PARALYSIS |
1 |
0.0007 |
| 169 |
GENERALISED ANXIETY DISORDER |
1 |
0.0007 |
| 170 |
ANKLE OPERATION |
1 |
0.0007 |
| 171 |
TOBACCO USER |
1 |
0.0007 |
| 172 |
SKIN STRIAE |
1 |
0.0007 |
| 173 |
ASTIGMATISM |
1 |
0.0007 |
| 174 |
BREAST PAIN |
7 |
0.0007 |
| 175 |
ECTOPIC PREGNANCY |
2 |
0.0006 |
| 176 |
INFERTILITY FEMALE |
1 |
0.0006 |
| 177 |
PRODUCT SUBSTITUTION ISSUE |
37 |
0.0006 |
| 178 |
BACTERIAL VAGINOSIS |
1 |
0.0006 |
| 179 |
INAPPROPRIATE AFFECT |
1 |
0.0006 |
| 180 |
VULVOVAGINAL PAIN |
3 |
0.0006 |
| 181 |
VEIN RUPTURE |
1 |
0.0006 |
| 182 |
EXPOSURE TO SARS-COV-2 |
1 |
0.0006 |
| 183 |
ENTERITIS INFECTIOUS |
1 |
0.0006 |
| 184 |
DEVICE ADHESION ISSUE |
9 |
0.0006 |
| 185 |
LACK OF INJECTION SITE ROTATION |
1 |
0.0006 |
| 186 |
INFUSION SITE DISCHARGE |
1 |
0.0006 |
| 187 |
PRODUCT COMMUNICATION ISSUE |
5 |
0.0006 |
| 188 |
TERMINAL INSOMNIA |
1 |
0.0006 |
| 189 |
BREAST CYST |
1 |
0.0006 |
| 190 |
DEVICE PLACEMENT ISSUE |
2 |
0.0006 |
| 191 |
INTRA-ABDOMINAL FLUID COLLECTION |
1 |
0.0006 |
| 192 |
UTERINE POLYP |
1 |
0.0006 |
| 193 |
DRUG MONITORING PROCEDURE NOT PERFORMED |
1 |
0.0006 |
| 194 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
3 |
0.0006 |
| 195 |
VULVOVAGINAL SWELLING |
1 |
0.0005 |
| 196 |
HYPERTRICHOSIS |
1 |
0.0005 |
| 197 |
SUNBURN |
4 |
0.0005 |
| 198 |
PARANASAL SINUS DISCOMFORT |
2 |
0.0005 |
| 199 |
MOTION SICKNESS |
1 |
0.0005 |
| 200 |
PRODUCT ADMINISTRATION INTERRUPTED |
4 |
0.0005 |
| 201 |
SKIN ODOUR ABNORMAL |
2 |
0.0005 |
| 202 |
DRUG DELIVERY SYSTEM ISSUE |
1 |
0.0005 |
| 203 |
EAR HAEMORRHAGE |
1 |
0.0005 |
| 204 |
SELF-INJURIOUS IDEATION |
2 |
0.0005 |
| 205 |
DEVICE MATERIAL ISSUE |
1 |
0.0005 |
| 206 |
NEUROGENIC BLADDER |
1 |
0.0005 |
| 207 |
EYE CONTUSION |
1 |
0.0005 |
| 208 |
INFUSION SITE BRUISING |
1 |
0.0005 |
| 209 |
GASTRIC BYPASS |
1 |
0.0005 |
| 210 |
CERVICAL DYSPLASIA |
1 |
0.0005 |
| 211 |
AMENORRHOEA |
8 |
0.0005 |
| 212 |
DANDRUFF |
1 |
0.0005 |
| 213 |
CHRONIC GASTRITIS |
1 |
0.0004 |
| 214 |
PUSTULE |
1 |
0.0004 |
| 215 |
MYOPIA |
1 |
0.0004 |
| 216 |
ENDOMETRIOSIS |
2 |
0.0004 |
| 217 |
WEIGHT ABNORMAL |
1 |
0.0004 |
| 218 |
WRONG DOSE |
1 |
0.0004 |
| 219 |
LYMPHADENITIS |
1 |
0.0004 |
| 220 |
BLINDNESS TRANSIENT |
3 |
0.0004 |
| 221 |
VENTRICULAR HYPERTROPHY |
1 |
0.0004 |
| 222 |
VAGINAL DISCHARGE |
4 |
0.0004 |
| 223 |
INCORRECT DRUG ADMINISTRATION DURATION |
11 |
0.0004 |
| 224 |
PRODUCT COLOUR ISSUE |
2 |
0.0004 |
| 225 |
DRUG TITRATION ERROR |
1 |
0.0004 |
| 226 |
PRODUCT DOSE OMISSION |
25 |
0.0004 |
| 227 |
PROTEIN TOTAL INCREASED |
1 |
0.0004 |
| 228 |
PRODUCT SIZE ISSUE |
2 |
0.0004 |
| 229 |
SKIN DISCOMFORT |
1 |
0.0004 |
| 230 |
SKIN WRINKLING |
1 |
0.0004 |
| 231 |
HYPOMENORRHOEA |
1 |
0.0004 |
| 232 |
TRICHORRHEXIS |
1 |
0.0004 |
| 233 |
PRODUCT LEAKAGE |
2 |
0.0004 |
| 234 |
CEREBRAL THROMBOSIS |
1 |
0.0004 |
| 235 |
VITAMIN B12 DECREASED |
1 |
0.0003 |
| 236 |
WRONG PATIENT RECEIVED PRODUCT |
1 |
0.0003 |
| 237 |
NECK INJURY |
1 |
0.0003 |
| 238 |
ACNE CYSTIC |
1 |
0.0003 |
| 239 |
MEDICAL DEVICE DISCOMFORT |
1 |
0.0003 |
| 240 |
BRAIN DEATH |
1 |
0.0003 |
| 241 |
EYELIDS PRURITUS |
1 |
0.0003 |
| 242 |
FLANK PAIN |
3 |
0.0003 |
| 243 |
ABDOMINAL ADHESIONS |
1 |
0.0003 |
| 244 |
PRODUCT PACKAGING ISSUE |
3 |
0.0003 |
| 245 |
VULVOVAGINAL DRYNESS |
1 |
0.0003 |
| 246 |
HEPATIC NEOPLASM |
1 |
0.0003 |
| 247 |
COELIAC DISEASE |
3 |
0.0003 |
| 248 |
SKIN IRRITATION |
14 |
0.0003 |
| 249 |
BREAST ENLARGEMENT |
1 |
0.0003 |
| 250 |
NEAR DEATH EXPERIENCE |
1 |
0.0003 |
| 251 |
ANXIETY DISORDER |
1 |
0.0003 |
| 252 |
PLANTAR FASCIITIS |
1 |
0.0003 |
| 253 |
TONGUE ULCERATION |
1 |
0.0003 |
| 254 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
21 |
0.0003 |
| 255 |
CAROTID ARTERY STENOSIS |
1 |
0.0003 |
| 256 |
SKIN REACTION |
4 |
0.0003 |
| 257 |
DEPRESSIVE SYMPTOM |
1 |
0.0003 |
| 258 |
APPENDICECTOMY |
1 |
0.0003 |
| 259 |
FRUSTRATION |
1 |
0.0003 |
| 260 |
IMPAIRED QUALITY OF LIFE |
4 |
0.0003 |
| 261 |
PHARYNGITIS STREPTOCOCCAL |
3 |
0.0003 |
| 262 |
COMPLICATION ASSOCIATED WITH DEVICE |
4 |
0.0003 |
| 263 |
CAROTID ARTERY OCCLUSION |
1 |
0.0003 |
| 264 |
MAJOR DEPRESSION |
2 |
0.0003 |
| 265 |
UTERINE LEIOMYOMA |
2 |
0.0003 |
| 266 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
5 |
0.0003 |
| 267 |
SENSITIVE SKIN |
2 |
0.0003 |
| 268 |
PAROSMIA |
2 |
0.0003 |
| 269 |
CATHETER SITE INFECTION |
1 |
0.0003 |
| 270 |
LOSS OF CONTROL OF LEGS |
1 |
0.0003 |
| 271 |
OESOPHAGEAL DISORDER |
1 |
0.0003 |
| 272 |
OFF LABEL USE |
226 |
0.0003 |
| 273 |
MOOD ALTERED |
7 |
0.0003 |
| 274 |
VENOUS THROMBOSIS |
1 |
0.0003 |
| 275 |
FURUNCLE |
2 |
0.0003 |
| 276 |
CEREBRAL ATROPHY |
1 |
0.0003 |
| 277 |
NO ADVERSE EVENT |
45 |
0.0002 |
| 278 |
PRODUCT PHYSICAL ISSUE |
5 |
0.0002 |
| 279 |
ENURESIS |
1 |
0.0002 |
| 280 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
1 |
0.0002 |
| 281 |
PERIPHERAL VENOUS DISEASE |
1 |
0.0002 |
| 282 |
PHOTOSENSITIVITY REACTION |
4 |
0.0002 |
| 283 |
MIGRAINE |
23 |
0.0002 |
| 284 |
EMBOLISM |
2 |
0.0002 |
| 285 |
SLEEP TERROR |
1 |
0.0002 |
| 286 |
INTESTINAL STENOSIS |
1 |
0.0002 |
| 287 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
13 |
0.0002 |
| 288 |
THROAT CANCER |
1 |
0.0002 |
| 289 |
HEPATIC PAIN |
1 |
0.0002 |
| 290 |
PRODUCT DISPENSING ISSUE |
1 |
0.0002 |
| 291 |
ONYCHOMYCOSIS |
1 |
0.0002 |
| 292 |
INTENTIONAL DEVICE MISUSE |
1 |
0.0002 |
| 293 |
VULVOVAGINAL DISCOMFORT |
1 |
0.0002 |
| 294 |
ABORTION SPONTANEOUS |
9 |
0.0002 |
| 295 |
ACNE |
17 |
0.0002 |
| 296 |
ILEUS PARALYTIC |
1 |
0.0002 |
| 297 |
FACIAL PAIN |
2 |
0.0002 |
| 298 |
IMPLANT SITE PAIN |
1 |
0.0002 |
| 299 |
VASCULAR DEVICE INFECTION |
1 |
0.0002 |
| 300 |
BLOOD PRESSURE SYSTOLIC DECREASED |
1 |
0.0002 |
| 301 |
DYSPAREUNIA |
1 |
0.0002 |
| 302 |
HUNGER |
3 |
0.0002 |
| 303 |
SKIN TIGHTNESS |
1 |
0.0002 |
| 304 |
ABDOMINAL DISTENSION |
22 |
0.0002 |
| 305 |
MEDICATION RESIDUE PRESENT |
1 |
0.0002 |
| 306 |
INCREASED APPETITE |
4 |
0.0002 |
| 307 |
ENTEROCOCCAL INFECTION |
1 |
0.0002 |
| 308 |
RASH VESICULAR |
1 |
0.0002 |
| 309 |
DIZZINESS POSTURAL |
2 |
0.0002 |
| 310 |
PHARYNGEAL SWELLING |
2 |
0.0002 |
| 311 |
COMPLICATION OF DEVICE INSERTION |
4 |
0.0002 |
| 312 |
INJECTION SITE INFLAMMATION |
1 |
0.0002 |
| 313 |
PETIT MAL EPILEPSY |
1 |
0.0002 |
| 314 |
WEIGHT FLUCTUATION |
2 |
0.0002 |
| 315 |
PRODUCT USE IN UNAPPROVED INDICATION |
47 |
0.0002 |
| 316 |
SCRATCH |
2 |
0.0002 |
| 317 |
INTESTINAL RESECTION |
1 |
0.0002 |
| 318 |
BRUXISM |
1 |
0.0002 |
| 319 |
HIP SURGERY |
1 |
0.0002 |
| 320 |
BLOOD GLUCOSE FLUCTUATION |
2 |
0.0002 |
| 321 |
ASTHENOPIA |
1 |
0.0002 |
| 322 |
HAEMORRHAGE |
19 |
0.0002 |
| 323 |
CYSTIC FIBROSIS |
1 |
0.0002 |
| 324 |
STREPTOCOCCAL INFECTION |
1 |
0.0002 |
| 325 |
INTESTINAL PERFORATION |
2 |
0.0002 |
| 326 |
CHOLECYSTITIS ACUTE |
1 |
0.0002 |
| 327 |
SKIN DISCOLOURATION |
8 |
0.0002 |
| 328 |
THROMBOSIS |
14 |
0.0002 |
| 329 |
HYPERTRIGLYCERIDAEMIA |
1 |
0.0002 |
| 330 |
FEELING OF BODY TEMPERATURE CHANGE |
1 |
0.0002 |
| 331 |
URINE ODOUR ABNORMAL |
1 |
0.0002 |
| 332 |
DECREASED INTEREST |
1 |
0.0002 |
| 333 |
DRUG DOSE OMISSION |
28 |
0.0002 |
| 334 |
DRUG EFFECT DECREASED |
9 |
0.0002 |
| 335 |
TYPE 1 DIABETES MELLITUS |
1 |
0.0002 |
| 336 |
HEPATITIS B |
1 |
0.0002 |
| 337 |
CONTRAINDICATED PRODUCT ADMINISTERED |
5 |
0.0002 |
| 338 |
DERMATITIS ACNEIFORM |
1 |
0.0002 |
| 339 |
VULVOVAGINAL BURNING SENSATION |
1 |
0.0002 |
| 340 |
EMOTIONAL DISORDER |
5 |
0.0002 |
| 341 |
PRE-EXISTING CONDITION IMPROVED |
1 |
0.0002 |
| 342 |
EPSTEIN-BARR VIRUS INFECTION |
1 |
0.0002 |
| 343 |
INFUSION SITE SWELLING |
1 |
0.0002 |
| 344 |
BLEPHAROSPASM |
1 |
0.0002 |
| 345 |
PULMONARY EMBOLISM |
15 |
0.0002 |
| 346 |
THERAPEUTIC RESPONSE CHANGED |
1 |
0.0002 |
| 347 |
MATERNAL EXPOSURE DURING PREGNANCY |
14 |
0.0002 |
| 348 |
SCREAMING |
1 |
0.0002 |
| 349 |
POST PROCEDURAL COMPLICATION |
3 |
0.0002 |
| 350 |
SOMNAMBULISM |
1 |
0.0002 |
| 351 |
PRODUCT FORMULATION ISSUE |
1 |
0.0002 |
| 352 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
7 |
0.0001 |
| 353 |
SKIN MASS |
1 |
0.0001 |
| 354 |
POST-TRAUMATIC STRESS DISORDER |
1 |
0.0001 |
| 355 |
POSTOPERATIVE WOUND INFECTION |
1 |
0.0001 |
| 356 |
FEEDING DISORDER |
3 |
0.0001 |
| 357 |
THROAT TIGHTNESS |
4 |
0.0001 |
| 358 |
ANGER |
5 |
0.0001 |
| 359 |
GENERAL PHYSICAL CONDITION ABNORMAL |
1 |
0.0001 |
| 360 |
IMPAIRED GASTRIC EMPTYING |
2 |
0.0001 |
| 361 |
PRODUCT DOSE OMISSION ISSUE |
43 |
0.0001 |
| 362 |
DROOLING |
1 |
0.0001 |
| 363 |
PAPULE |
1 |
0.0001 |
| 364 |
PANIC REACTION |
1 |
0.0001 |
| 365 |
WEIGHT INCREASED |
31 |
0.0001 |
| 366 |
PRODUCT USE ISSUE |
26 |
0.0001 |
| 367 |
PRODUCT PRESCRIBING ISSUE |
3 |
0.0001 |
| 368 |
CLOSTRIDIUM DIFFICILE INFECTION |
3 |
0.0001 |
| 369 |
ORAL DISORDER |
1 |
0.0001 |
| 370 |
ARTHROPOD BITE |
1 |
0.0001 |
| 371 |
FEELING DRUNK |
1 |
0.0001 |
| 372 |
ECZEMA |
7 |
0.0001 |
| 373 |
IRRITABILITY |
8 |
0.0001 |
| 374 |
DERMATITIS ATOPIC |
7 |
0.0001 |
| 375 |
TROPONIN INCREASED |
1 |
0.0001 |
| 376 |
URTICARIA |
22 |
0.0001 |
| 377 |
ABDOMINAL PAIN UPPER |
27 |
0.0001 |
| 378 |
INSURANCE ISSUE |
2 |
0.0001 |
| 379 |
MUSCLE SPASMS |
24 |
0.0001 |
| 380 |
BOWEL MOVEMENT IRREGULARITY |
1 |
0.0001 |
| 381 |
LIMB DISCOMFORT |
4 |
0.0001 |
| 382 |
CONCUSSION |
1 |
0.0001 |
| 383 |
ABDOMINAL PAIN |
30 |
0.0001 |
| 384 |
BRAIN FOG |
2 |
0.0001 |
| 385 |
ILLNESS |
13 |
0.0001 |
| 386 |
RENAL CYST |
1 |
0.0001 |
| 387 |
PRODUCT STORAGE ERROR |
11 |
0.0001 |
| 388 |
RASH ERYTHEMATOUS |
6 |
0.0001 |
| 389 |
NIGHT SWEATS |
4 |
0.0001 |
| 390 |
RHINITIS |
1 |
0.0001 |
| 391 |
FRUSTRATION TOLERANCE DECREASED |
1 |
0.0001 |
| 392 |
PRESYNCOPE |
3 |
0.0001 |
| 393 |
HYPERAESTHESIA |
1 |
0.0001 |
| 394 |
ESCHERICHIA INFECTION |
1 |
0.0001 |
| 395 |
THERAPEUTIC RESPONSE SHORTENED |
4 |
0.0001 |
| 396 |
EXPIRED PRODUCT ADMINISTERED |
4 |
0.0001 |
| 397 |
VIRAL INFECTION |
4 |
0.0001 |
| 398 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
4 |
0.0001 |
| 399 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
2 |
0.0001 |
| 400 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
2 |
0.0001 |
| 401 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
21 |
0.0001 |
| 402 |
SKIN HYPERPIGMENTATION |
1 |
0.0001 |
| 403 |
PSYCHOLOGICAL TRAUMA |
1 |
0.0001 |
| 404 |
HYSTERECTOMY |
1 |
0.0001 |
| 405 |
BURNING SENSATION |
8 |
0.0001 |
| 406 |
FOREIGN BODY IN REPRODUCTIVE TRACT |
1 |
0.0001 |
| 407 |
GASTROINTESTINAL INFECTION |
1 |
0.0001 |
| 408 |
LOSS OF LIBIDO |
1 |
0.0001 |
| 409 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
4 |
0.0001 |
| 410 |
CRYING |
4 |
0.0001 |
| 411 |
PANIC ATTACK |
4 |
0.0001 |
| 412 |
BRAIN NEOPLASM |
1 |
0.0001 |
| 413 |
RASH |
47 |
0.0001 |
| 414 |
PERSONALITY CHANGE |
1 |
0.0001 |
| 415 |
MIDDLE INSOMNIA |
2 |
0.0001 |
| 416 |
DEFORMITY |
1 |
0.0001 |
| 417 |
BLISTER |
6 |
0.0001 |
| 418 |
SKIN EXFOLIATION |
9 |
0.0001 |
| 419 |
ABORTION INDUCED |
1 |
0.0001 |
| 420 |
BLOOD URINE PRESENT |
2 |
0.0001 |
| 421 |
INTENTIONAL DOSE OMISSION |
3 |
0.0001 |
| 422 |
SLEEP APNOEA SYNDROME |
2 |
0.0001 |
| 423 |
AFFECT LABILITY |
1 |
0.0001 |
| 424 |
HERNIA |
2 |
0.0001 |
| 425 |
VITAMIN D DEFICIENCY |
1 |
0.0001 |
| 426 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
3 |
0.0001 |
| 427 |
HYPERSENSITIVITY |
19 |
0.0001 |
| 428 |
SURGERY |
6 |
0.0001 |
| 429 |
SKIN FISSURES |
2 |
0.0001 |
| 430 |
DISABILITY |
2 |
0.0001 |
| 431 |
BRAIN INJURY |
1 |
0.0001 |
| 432 |
PRODUCT ADMINISTRATION ERROR |
2 |
0.0001 |
| 433 |
DRY THROAT |
1 |
0.0001 |
| 434 |
DISCOMFORT |
6 |
0.0001 |
| 435 |
THERAPY INTERRUPTED |
7 |
0.0001 |
| 436 |
INJECTION SITE RASH |
3 |
0.0001 |
| 437 |
EUPHORIC MOOD |
1 |
0.0001 |
| 438 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 439 |
EAR DISCOMFORT |
1 |
0.0001 |
| 440 |
TEMPERATURE INTOLERANCE |
1 |
0.0001 |
| 441 |
CYSTITIS |
3 |
0.0001 |
| 442 |
HEADACHE |
59 |
0.0001 |
| 443 |
IMPAIRED WORK ABILITY |
2 |
0.0001 |
| 444 |
BODY HEIGHT DECREASED |
1 |
0.0001 |
| 445 |
IRRITABLE BOWEL SYNDROME |
2 |
0.0001 |
| 446 |
PRURITUS GENERALISED |
2 |
0.0001 |
| 447 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
2 |
0.0001 |
| 448 |
DEPRESSION |
21 |
0.0001 |
| 449 |
BIPOLAR DISORDER |
1 |
0.0001 |
| 450 |
BACK INJURY |
1 |
0.0001 |
| 451 |
TREATMENT NONCOMPLIANCE |
5 |
0.0001 |
| 452 |
STAPHYLOCOCCAL INFECTION |
3 |
0.0001 |
| 453 |
FUNGAL INFECTION |
3 |
0.0001 |
| 454 |
NERVE INJURY |
1 |
0.0001 |
| 455 |
HYPERTENSIVE CRISIS |
1 |
0.0001 |
| 456 |
THERAPEUTIC RESPONSE UNEXPECTED |
4 |
0.0001 |
| 457 |
ADVERSE DRUG REACTION |
8 |
0.0001 |
| 458 |
REBOUND EFFECT |
1 |
0.0001 |
| 459 |
FLATULENCE |
5 |
0.0001 |
| 460 |
ANXIETY |
25 |
0.0001 |
| 461 |
PRODUCT AVAILABILITY ISSUE |
2 |
0.0001 |
| 462 |
SCAB |
1 |
0.0001 |
| 463 |
INTERNAL HAEMORRHAGE |
1 |
0.0001 |
| 464 |
SUICIDAL IDEATION |
8 |
0.0001 |
| 465 |
INJECTION SITE REACTION |
6 |
0.0001 |
| 466 |
MUSCLE TWITCHING |
2 |
0.0001 |
| 467 |
NIGHTMARE |
3 |
0.0001 |
| 468 |
SEIZURE |
10 |
0.0001 |
| 469 |
NAUSEA |
68 |
0.0001 |
| 470 |
CAESAREAN SECTION |
1 |
0.0001 |
| 471 |
SWELLING |
8 |
0.0001 |
| 472 |
SEXUAL DYSFUNCTION |
1 |
0.0001 |
| 473 |
MUSCLE RIGIDITY |
1 |
0.0001 |
| 474 |
FEELING HOT |
5 |
0.0001 |
| 475 |
INJECTION SITE URTICARIA |
2 |
0.0001 |
| 476 |
GLOMERULAR FILTRATION RATE DECREASED |
1 |
0.0001 |
| 477 |
SMALL INTESTINAL OBSTRUCTION |
1 |
0.0001 |
| 478 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 479 |
HYPOAESTHESIA |
12 |
0.0001 |
| 480 |
INTENTIONAL PRODUCT MISUSE |
7 |
0.0001 |
| 481 |
ASTHMA |
9 |
0.0001 |
| 482 |
HOT FLUSH |
6 |
0.0001 |
| 483 |
BRAIN OEDEMA |
1 |
0.0001 |
| 484 |
PRODUCT COMPLAINT |
2 |
0.0001 |
| 485 |
FLUID RETENTION |
4 |
0.0001 |
| 486 |
GASTROINTESTINAL DISORDER |
7 |
0.0001 |
| 487 |
RASH GENERALISED |
2 |
0.0001 |
| 488 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 489 |
ABNORMAL BEHAVIOUR |
3 |
0.0001 |
| 490 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 491 |
SINUS CONGESTION |
1 |
0.0001 |
| 492 |
PSORIATIC ARTHROPATHY |
3 |
0.0001 |
| 493 |
DEVICE OCCLUSION |
1 |
0.0001 |
| 494 |
VOMITING |
33 |
0.0001 |
| 495 |
PARALYSIS |
1 |
0.0001 |
| 496 |
HYPERSOMNIA |
2 |
0.0001 |
| 497 |
HYPOKINESIA |
1 |
0.0001 |
| 498 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 499 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 500 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 501 |
THERAPEUTIC RESPONSE DECREASED |
4 |
0.0001 |
| 502 |
ABDOMINAL DISCOMFORT |
11 |
0.0001 |
| 503 |
DRUG DISPENSING ERROR |
1 |
0.0001 |
| 504 |
TINNITUS |
3 |
0.0001 |
| 505 |
PRURITUS |
25 |
0.0001 |
| 506 |
DEVICE RELATED INFECTION |
1 |
0.0001 |
| 507 |
TENDONITIS |
1 |
0.0001 |
| 508 |
DELUSION |
1 |
0.0001 |
| 509 |
EXPOSURE DURING PREGNANCY |
4 |
0.0001 |
| 510 |
MENINGIOMA |
1 |
0.0001 |
| 511 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 512 |
PREMATURE DELIVERY |
1 |
0.0001 |
| 513 |
OBESITY |
1 |
0.0001 |
| 514 |
SCIATICA |
1 |
0.0001 |
| 515 |
LOSS OF CONSCIOUSNESS |
8 |
0.0001 |
| 516 |
HYPERHIDROSIS |
8 |
0.0001 |
| 517 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
| 518 |
DEEP VEIN THROMBOSIS |
4 |
0.0001 |
| 519 |
BACK DISORDER |
1 |
0.0001 |
| 520 |
METASTASES TO BONE |
1 |
0.0001 |
| 521 |
EYE DISORDER |
2 |
0.0001 |
| 522 |
MANIA |
1 |
0.0001 |
| 523 |
HEART RATE INCREASED |
6 |
0.0001 |
| 524 |
PSYCHOMOTOR HYPERACTIVITY |
1 |
0.0001 |
| 525 |
LIP SWELLING |
2 |
0.0001 |
| 526 |
SKIN DISORDER |
2 |
0.0001 |
| 527 |
AGGRESSION |
3 |
0.0001 |
| 528 |
FACE OEDEMA |
1 |
0.0001 |
| 529 |
SINUSITIS |
6 |
0.0001 |
| 530 |
THERAPY CESSATION |
3 |
0.0001 |
| 531 |
FEELING ABNORMAL |
14 |
0.0001 |
| 532 |
PERIPHERAL SWELLING |
9 |
0.0001 |
| 533 |
SCAR |
1 |
0.0001 |
| 534 |
DIZZINESS |
29 |
0.0001 |
| 535 |
LOCAL SWELLING |
1 |
0.0001 |
| 536 |
INTENTIONAL PRODUCT USE ISSUE |
5 |
0.0001 |
| 537 |
DEPRESSED MOOD |
3 |
0.0001 |
| 538 |
COLD SWEAT |
1 |
0.0001 |
| 539 |
SLEEP DISORDER |
4 |
0.0001 |
| 540 |
DRUG ERUPTION |
1 |
0.0001 |
| 541 |
TACHYCARDIA |
5 |
0.0001 |
| 542 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 543 |
THIRST |
1 |
0.0001 |
| 544 |
CEREBRAL HAEMORRHAGE |
2 |
0.0001 |
| 545 |
DISTURBANCE IN ATTENTION |
3 |
0.0001 |
| 546 |
GASTROENTERITIS VIRAL |
1 |
0.0001 |
| 547 |
COMPLICATION OF DEVICE REMOVAL |
1 |
0.0001 |
| 548 |
DRUG EFFECT INCOMPLETE |
2 |
0.0001 |
| 549 |
PELVIC PAIN |
1 |
0.0001 |
| 550 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 551 |
HAEMATOCHEZIA |
3 |
0.0001 |
| 552 |
PAIN IN EXTREMITY |
16 |
0.0001 |
| 553 |
ANAPHYLACTIC REACTION |
3 |
0.0001 |
| 554 |
ADVERSE EVENT |
5 |
0.0001 |
| 555 |
BLOOD GLUCOSE ABNORMAL |
1 |
0.0001 |
| 556 |
INJECTION SITE MASS |
2 |
0.0001 |
| 557 |
INFLUENZA |
6 |
0.0001 |
| 558 |
HEPATIC STEATOSIS |
1 |
0.0001 |
| 559 |
THINKING ABNORMAL |
1 |
0.0001 |
| 560 |
UNEVALUABLE EVENT |
4 |
0.0001 |
| 561 |
DRY SKIN |
7 |
0.0001 |
| 562 |
DRUG PRESCRIBING ERROR |
1 |
0.0001 |
| 563 |
ERUCTATION |
1 |
0.0001 |
| 564 |
DYSTONIA |
1 |
0.0001 |
| 565 |
EAR PAIN |
1 |
0.0001 |
| 566 |
KIDNEY INFECTION |
1 |
0.0001 |
| 567 |
MEMORY IMPAIRMENT |
7 |
0.0001 |
| 568 |
ALOPECIA |
10 |
0.0001 |
| 569 |
DRUG INEFFECTIVE |
67 |
0.0001 |
| 570 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
1 |
0.0001 |
| 571 |
SINUS DISORDER |
1 |
0.0001 |
| 572 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 573 |
SYNCOPE |
5 |
0.0000 |
| 574 |
PREGNANCY |
1 |
0.0000 |
| 575 |
GASTROOESOPHAGEAL REFLUX DISEASE |
4 |
0.0000 |
| 576 |
VERTIGO |
3 |
0.0000 |
| 577 |
BLINDNESS |
2 |
0.0000 |
| 578 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 579 |
PAIN |
30 |
0.0000 |
| 580 |
ERYTHEMA |
10 |
0.0000 |
| 581 |
INJECTION SITE WARMTH |
1 |
0.0000 |
| 582 |
PULMONARY HYPERTENSION |
1 |
0.0000 |
| 583 |
POLLAKIURIA |
2 |
0.0000 |
| 584 |
DERMATITIS |
1 |
0.0000 |
| 585 |
FATIGUE |
37 |
0.0000 |
| 586 |
BACK PAIN |
11 |
0.0000 |
| 587 |
RETCHING |
1 |
0.0000 |
| 588 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 589 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 590 |
DEVICE LEAKAGE |
2 |
0.0000 |
| 591 |
DEVICE DISLOCATION |
2 |
0.0000 |
| 592 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 593 |
SNEEZING |
1 |
0.0000 |
| 594 |
CHROMATURIA |
1 |
0.0000 |
| 595 |
INCORRECT DOSE ADMINISTERED |
10 |
0.0000 |
| 596 |
VISION BLURRED |
6 |
0.0000 |
| 597 |
OCULAR HYPERAEMIA |
2 |
0.0000 |
| 598 |
DISEASE RECURRENCE |
2 |
0.0000 |
| 599 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 600 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
2 |
0.0000 |
| 601 |
INFECTION |
6 |
0.0000 |
| 602 |
FIBROMYALGIA |
1 |
0.0000 |
| 603 |
NEURALGIA |
1 |
0.0000 |
| 604 |
UNDERDOSE |
3 |
0.0000 |
| 605 |
HALLUCINATION |
3 |
0.0000 |
| 606 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 607 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 608 |
HYPOPHAGIA |
1 |
0.0000 |
| 609 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 610 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 611 |
SPEECH DISORDER |
2 |
0.0000 |
| 612 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
1 |
0.0000 |
| 613 |
PARAESTHESIA |
6 |
0.0000 |
| 614 |
JOINT STIFFNESS |
1 |
0.0000 |
| 615 |
GASTRITIS |
1 |
0.0000 |
| 616 |
HYPERTENSION |
8 |
0.0000 |
| 617 |
EAR INFECTION |
1 |
0.0000 |
| 618 |
DEHYDRATION |
5 |
0.0000 |
| 619 |
JAUNDICE |
1 |
0.0000 |
| 620 |
PAIN OF SKIN |
1 |
0.0000 |
| 621 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 622 |
MALAISE |
16 |
0.0000 |
| 623 |
RESPIRATORY ARREST |
1 |
0.0000 |
| 624 |
ABNORMAL DREAMS |
1 |
0.0000 |
| 625 |
TREATMENT FAILURE |
3 |
0.0000 |
| 626 |
MEDICATION ERROR |
2 |
0.0000 |
| 627 |
FEELING COLD |
1 |
0.0000 |
| 628 |
HAEMOPTYSIS |
1 |
0.0000 |
| 629 |
NECK PAIN |
2 |
0.0000 |
| 630 |
MUSCULAR WEAKNESS |
4 |
0.0000 |
| 631 |
URINARY TRACT INFECTION |
6 |
0.0000 |
| 632 |
BALANCE DISORDER |
3 |
0.0000 |
| 633 |
DECREASED APPETITE |
8 |
0.0000 |
| 634 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 635 |
DYSSTASIA |
1 |
0.0000 |
| 636 |
MUSCULOSKELETAL STIFFNESS |
3 |
0.0000 |
| 637 |
COVID-19 |
6 |
0.0000 |
| 638 |
PALPITATIONS |
4 |
0.0000 |
| 639 |
NASAL CONGESTION |
2 |
0.0000 |
| 640 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 641 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 642 |
PSYCHOTIC DISORDER |
1 |
0.0000 |
| 643 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 644 |
RENAL INJURY |
1 |
0.0000 |
| 645 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 646 |
DRUG ADMINISTRATION ERROR |
1 |
0.0000 |
| 647 |
NASOPHARYNGITIS |
6 |
0.0000 |
| 648 |
OROPHARYNGEAL PAIN |
3 |
0.0000 |
| 649 |
WEIGHT DECREASED |
9 |
0.0000 |
| 650 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 651 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 652 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 653 |
DIARRHOEA |
20 |
0.0000 |
| 654 |
DEVICE EXPULSION |
2 |
0.0000 |
| 655 |
AMNESIA |
2 |
0.0000 |
| 656 |
SWELLING FACE |
2 |
0.0000 |
| 657 |
DYSPEPSIA |
3 |
0.0000 |
| 658 |
INSOMNIA |
8 |
0.0000 |
| 659 |
EYE PRURITUS |
1 |
0.0000 |
| 660 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 661 |
CONDITION AGGRAVATED |
9 |
0.0000 |
| 662 |
HEPATIC ENZYME INCREASED |
2 |
0.0000 |
| 663 |
CHEST DISCOMFORT |
3 |
0.0000 |
| 664 |
DELIRIUM |
1 |
0.0000 |
| 665 |
RASH MACULAR |
1 |
0.0000 |
| 666 |
HEART RATE DECREASED |
1 |
0.0000 |
| 667 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 668 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
2 |
0.0000 |
| 669 |
RESTLESSNESS |
1 |
0.0000 |
| 670 |
AGITATION |
2 |
0.0000 |
| 671 |
CHEST PAIN |
5 |
0.0000 |
| 672 |
EYE SWELLING |
1 |
0.0000 |
| 673 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 674 |
GAIT DISTURBANCE |
5 |
0.0000 |
| 675 |
CHILLS |
3 |
0.0000 |
| 676 |
DISORIENTATION |
1 |
0.0000 |
| 677 |
INJECTION SITE HAEMORRHAGE |
2 |
0.0000 |
| 678 |
JOINT SWELLING |
3 |
0.0000 |
| 679 |
SOMNOLENCE |
5 |
0.0000 |
| 680 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 681 |
DEVICE BREAKAGE |
1 |
0.0000 |
| 682 |
DYSKINESIA |
1 |
0.0000 |
| 683 |
INFLUENZA LIKE ILLNESS |
2 |
0.0000 |
| 684 |
VISUAL IMPAIRMENT |
3 |
0.0000 |
| 685 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 686 |
WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 687 |
CEREBROVASCULAR ACCIDENT |
4 |
0.0000 |
| 688 |
HYPOACUSIS |
1 |
0.0000 |
| 689 |
MENTAL DISORDER |
1 |
0.0000 |
| 690 |
DYSPNOEA |
13 |
0.0000 |
| 691 |
CONSTIPATION |
5 |
0.0000 |
| 692 |
INJECTION SITE PAIN |
7 |
0.0000 |
| 693 |
LIVER DISORDER |
1 |
0.0000 |
| 694 |
COLITIS ULCERATIVE |
1 |
0.0000 |
| 695 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 696 |
THROAT IRRITATION |
1 |
0.0000 |
| 697 |
LOWER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 698 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 699 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 700 |
CARDIAC DISORDER |
2 |
0.0000 |
| 701 |
DYSPHAGIA |
2 |
0.0000 |
| 702 |
NEUROPATHY PERIPHERAL |
2 |
0.0000 |
| 703 |
LUNG DISORDER |
1 |
0.0000 |
| 704 |
PYREXIA |
7 |
0.0000 |
| 705 |
CELLULITIS |
1 |
0.0000 |
| 706 |
FLUSHING |
2 |
0.0000 |
| 707 |
HOSPITALISATION |
3 |
0.0000 |
| 708 |
INFLAMMATION |
1 |
0.0000 |
| 709 |
ARTHRALGIA |
8 |
0.0000 |
| 710 |
NERVOUSNESS |
1 |
0.0000 |
| 711 |
PANCREATITIS |
1 |
0.0000 |
| 712 |
ASTHENIA |
7 |
0.0000 |
| 713 |
RASH PRURITIC |
1 |
0.0000 |
| 714 |
SEPSIS |
2 |
0.0000 |
| 715 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 716 |
EYE PAIN |
1 |
0.0000 |
| 717 |
HERPES ZOSTER |
1 |
0.0000 |
| 718 |
LETHARGY |
1 |
0.0000 |
| 719 |
EYE IRRITATION |
1 |
0.0000 |
| 720 |
DYSPHONIA |
1 |
0.0000 |
| 721 |
WHEEZING |
1 |
0.0000 |
| 722 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 723 |
INJECTION SITE ERYTHEMA |
2 |
0.0000 |
| 724 |
RHINORRHOEA |
1 |
0.0000 |
| 725 |
PSORIASIS |
2 |
0.0000 |
| 726 |
DEVICE DIFFICULT TO USE |
1 |
0.0000 |
| 727 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 728 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 729 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 730 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 731 |
COUGH |
4 |
0.0000 |
| 732 |
INJURY |
1 |
0.0000 |
| 733 |
MOBILITY DECREASED |
1 |
0.0000 |
| 734 |
BRONCHITIS |
1 |
0.0000 |
| 735 |
DYSGEUSIA |
1 |
0.0000 |
| 736 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 737 |
ARTHRITIS |
1 |
0.0000 |
| 738 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 739 |
CARDIAC FAILURE |
1 |
0.0000 |
| 740 |
PNEUMONIA |
4 |
0.0000 |
| 741 |
DRY MOUTH |
1 |
0.0000 |
| 742 |
FOETAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 743 |
TREMOR |
2 |
0.0000 |
| 744 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 745 |
MYALGIA |
2 |
0.0000 |
| 746 |
DRUG WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 747 |
DEVICE ISSUE |
1 |
0.0000 |
| 748 |
ANAEMIA |
2 |
0.0000 |
| 749 |
CONTUSION |
1 |
0.0000 |
| 750 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 751 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 752 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 753 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 754 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 755 |
DRUG INTERACTION |
1 |
0.0000 |
| 756 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 757 |
FALL |
2 |
0.0000 |
| 758 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 759 |
HYPOTENSION |
1 |
0.0000 |
| 760 |
DEATH |
3 |
0.0000 |